Skip to main content

NCI at ASCO Annual Meeting 2022

In addition to the sessions noted below, please view the American Society of Clinical Oncology (ASCO) Annual Meeting 2022 program guide to find poster sessions featuring NCI staff participants.

All sessions listed are in central time (CT).

NCI Leadership Presentation

The meeting’s Opening Session took place from 9:30 a.m. to 12:00 p.m. on Saturday, June 4.
During this session, NCI Acting Director Douglas R. Lowy, M.D., presented the NCI Director’s Address (about 10:25–10:40 a.m.). The session followed the theme of the meeting, Advancing Equitable Cancer Care Through Innovation.

 

Cancer Research Opportunities, Funding, and Progress

Cancer Research Opportunities, Funding, and Progress

NCI Experts Participating in Panel Sessions

NCI experts joined their colleagues across the field of clinical oncology to participate in panel discussions during the meeting. View the presentation links for more information about each session. 

Panel Title NCI Presenter Date and Time

Adjuvant Therapy and Value-Based Decisions for Kidney and Urothelial Cancers: Does Early to Treat Equal Healthy, Wealthy, and Wise?

Andrea B. Apolo, M.D.

Friday, June 3 at 1:00 p.m.

Biomarkers for Screening, Diagnosis, Monitoring, and Surveillance of Head and Neck Cancers

Anil Chaturvedi, Ph.D.

Friday, June 3 at 1:00 p.m.

New Drugs in Oncology: Incorporation into Practice

Ramaprasad Srinivasan, M.D., Ph.D.

Friday, June 3 at 1:00 p.m.

ASCO Town Hall: The Future of the Conduct of Clinical Trials After COVID-19

Margaret M. Mooney, M.D.

Saturday, June 4 at 3:00 p.m.

Mentorship and Career Development Roundtable: A Discussion with ASCO’s Special Award Recipients

Ophira Ginsburg, M.D., F.R.C.P.C., M.Sc.

Saturday, June 4 at 1:15 p.m.

Less Is More: Practical De-Implementation Science Strategies to Improve Quality

Wynne Norton, Ph.D.

Sunday, June 5 at 4:30 p.m.

Immune Checkpoint Inhibitors: Long-Term Survival Data

Stephanie L. Goff, M.D.

Monday, June 6 at 9:45 a.m.

COVID-19 and Cancer: Advantages and Disadvantages of Immunotherapy

Elad Sharon, M.D., M.P.H.

Monday, June 6 at 11:30 a.m.

Symptoms and Survivorship

Kishan Pithadia, B.S.

Monday, June 6 at 11:30 a.m.

Depersonalized Medicine: Who Is Missing in Big Data?

Louis M. Staudt, M.D., Ph.D.

Monday, June 6 at 3:00 p.m.

Pediatric Oncology

Todd M. Gibson, Ph.D.

Monday, June 6 at 3:00 p.m.

NCI Exhibit Booth #4043

NCI staff were available at the NCI exhibit booth (#4043) to answer questions about NCI programs, resources, training, and opportunities.

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “NCI at ASCO Annual Meeting 2022 was originally published by the National Cancer Institute.”